FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Eywa Pharma Inc
Eywa Pharma Inc secured FDA approval for its ANDA 210211 covering Hydrocodone Bitartrate and Acetaminophen oral tablets, thereby granting the company a license to manufacture a generic version of the opioid painkiller and positioning it to capture market share in the established generic healthcare space.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day